Ascentage Pharma Stock Target Price and Analyst Consensus
| AAPG Stock | 35.46 1.38 4.05% |
Analysts of Ascentage Pharma render investment recommendations by dissecting financials, analyzing earning calls, and talking to Ascentage Pharma vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on Ascentage Pharma is currently unavailable. Please use our comprehensive buy-or-sell advice module to check the latest Macroaxis investment opinion on Ascentage Pharma
The Ascentage Pharma's current Gross Profit is estimated to increase to about 999.1 M, while Pretax Profit Margin is projected to decrease to (0.42). At this time, Ascentage Pharma's Current Deferred Revenue is most likely to increase significantly in the upcoming years. The Ascentage Pharma's current Net Debt is estimated to increase to about 453.5 M, while Short and Long Term Debt Total is projected to decrease to roughly 858 M. Ascentage | Build AI portfolio with Ascentage Stock |
It's important to approach Ascentage Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Ascentage Pharma price targets
Ascentage Pharma's stock target price is an estimate of its future price, usually made by analysts. Using Ascentage Pharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Ascentage Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ascentage Pharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Ascentage Pharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ascentage Pharma is a key component of Ascentage Pharma valuation and have some predictive power on the future returns of a Ascentage Pharma.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 100 shares | |
 | Disruptive Technologies Invested over 200 shares | |
 | Health Care ETFs Invested over 100 shares | |
| Size And Style ETFs Invested over 100 shares | |
| Sector ETFs Invested over 100 shares | |
 | Social Domain Invested over 100 shares | |
 | Millennials Best Invested over 100 shares | |
 | Macroaxis Index Invested over 90 shares | |
 | Dividend Beast Invested over 90 shares | |
 | Gold and Gold Mining Invested over 90 shares | |
 | Baby Boomer Prospects Invested over 90 shares | |
 | Impulse Invested over 90 shares |
Check out Macroaxis Advice on Ascentage Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.